KMTS KESTRA MEDICAL TECHNOLOGIES...

Nasdaq www.kestramedical.com


$ 27.40 $ 0.88 (3.25 %)    

Tuesday, 28-Oct-2025 18:15:17 EDT
QQQ $ 633.55 $ 4.83 (0.77 %)
DIA $ 476.83 $ 1.80 (0.38 %)
SPY $ 687.33 $ 1.82 (0.27 %)
TLT $ 92.10 $ 0.24 (0.26 %)
GLD $ 364.95 $ -2.63 (-0.72 %)
$ 27.95
$ 27.58
$ 18.00 x 5
$ 27.40 x 5
$ 27.08 - $ 28.40
$ 13.25 - $ 30.00
121,360
na
1.43B
$ 0.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-12-2025 07-31-2025 10-Q
2 07-17-2025 04-30-2025 10-K
3 04-17-2025 01-31-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) raises FY2026 sales outlook from $85.000 million to $88.000 million vs $85.074 million estim...

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of ...

Core News & Articles

Wells Fargo analyst Larry Biegelsen maintains Kestra Medical Techs (NASDAQ:KMTS) with a Overweight and lowers the price targ...

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(1.15) per share which missed the analyst consensus estimate o...

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) FY2026 Revenue expected to be more than $85.000M vs $82.972M Est

Core News & Articles

Kestra Medical Techs (NASDAQ: KMTS) sees FY2026 sales of $85.000 million vs $82.972 million analyst estimate.

Core News & Articles

Goldman Sachs analyst David Roman maintains Kestra Medical Techs (NASDAQ:KMTS) with a Neutral and lowers the price target fr...

Core News & Articles

Fiscal Year 2025 Revenue OutlookKestra expects revenue for fiscal year ending April 30, 2025 to be in the range of $58.0 millio...

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(1.25) per share. This is a 5.93 percent decrease over losses ...

Core News & Articles

Wolfe Research analyst Mike Polark initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Outperform rating and ann...

Core News & Articles

Wells Fargo analyst Larry Biegelsen initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Overweight rating and an...

Core News & Articles

Stifel analyst Rick Wise initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Buy rating and announces Price Targ...

Core News & Articles

Goldman Sachs analyst David Roman initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Neutral rating and announc...

Core News & Articles

Piper Sandler analyst Matt O'Brien initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Overweight rating and...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION